• SENSEX 74,559.97
    245.38 (+0.33%)
  • BANKNIFTY 56,055.75
    -236.70 (--0.42%)
  • HDFC Bank
    733.50 1,020.35(%)
  • ITC
    264.10 256.25(%)
  • The Bombay Burmah
    1,531.60 2,135.00(%)
  • Rentomojo
    492.20 480.00(%)
  • Glass Wall Syst.
    304.50 258.40(%)
  • Multi Comm. Exc.
    3,232.00 1,538.06(%)
  • UltraTech Cem.
    11,056.00 13,104.00(%)
  • EIH
    320.50 414.90(%)
  • Adani Total Gas
    674.80 859.70(%)
  • Bajaj Finance
    1,036.10 1,177.60(%)
  • Lords Mark Industries
    89.68 669.70(%)
  • Syrma SGS Tech.
    1,764.95 1,676.15(%)
  • Aditya Birla Cap
    404.25 430.55(%)
  • Atul
    6,195.10 7,198.20(%)
  • Karamtara Engg.
    378.20 351.95(%)
  • TCS
    2,101.50 1,976.00(%)
  • Aditya Infotech
    3,330.00 1,228.85(%)
  • Tata Chemicals
    690.10 581.30(%)
  • Bajaj Finserv
    1,843.25 1,598.15(%)
  • Allied Blenders
    641.40 382.70(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

IOL Chemicals & Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 1973.0
  • ISIN : INE485C01029
197.49 3 (1.50%)
  • As on 18 Sep 2026 (EOD)

  • Today’s Low

    189.37

  • Today’s High

    199.39

  • Open

    195.05

  • Perv Close

    194.57

  • 52W Low

    67.19

  • 52W High

    219.04

Key Indicators

  • P/E(TTM)

    32.80

  • Mar.Cap (₹Cr.)

    5,796.87

  • Div & Yield %

    0.51

  • Book Value(₹)

    61.27

  • Debt-Equity Ratio

    1.50

  • AGM Date

    17-Sep-2026

  • EPS

    6.02

  • P/E Ratio

    32.80

Financials Ratios

  • Debt-Equity Ratio

    0.04

  • Mar.Cap (₹Cr.)

    5,796.87

  • RONW (%)

    8.62

  • ROCE (%)

    12.21

Score Board

  • Equity (₹ in Cr.)

    58.71

  • BV (₹)

    61.30

  • Sales( ₹ in Cr.)

    2,319.06

  • NP (in Cr.)

    146.67

  • NP Var(%)

    45.0

  • Div%

    50.0

  • CPS (₹)

    7.70

  • EPS (₹)

    5.00

  • Traded Value (₹ in Lakhs)

    5,795.70

  • 52 Week High

    219.04

  • 52 Week Low

    67.19

  • Price BSE

    197.0

  • Price NSE

    197.00

  • Market Capital( in Cr.)

    5,795.70

  • P/C Ratio

    25.50

  • P/E Ratio

    39.40

  • Price Vs.BV

    5.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 2,319.06 2,079.21 2,132.79 2,217.11 2,184.02 1,966.98
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,319.06 2,079.21 2,132.79 2,217.11 2,184.02 1,966.98
Other Income 21.28 22.40 30.07 25.57 32.04 24.30
Stock Adjustments 18.53 -33.51 38.25 18.20 52.30 17.11
Total Income 2,358.87 2,068.10 2,201.11 2,260.88 2,268.36 2,008.39
EXPENDITURE :            
Raw Materials 1,505.63 1,358.34 1,435.20 1,565.29 1,622.81 1,119.95
Power and Fuel Cost 154.93 114.93 149.05 131.98 78.18 51.46
Employee Cost 248.26 216.57 201.02 168.21 141.30 115.55
Other Manufacturing Expenses 58.85 47.39 47.67 43.07 36.86 28.13
Selling and Administration Expenses 60.92 70.29 60.24 68.37 71.96 55.26
Miscellaneous Expenses 51.12 36.01 46.34 31.87 42.86 21.90
Employee Benefit Expenses 248.26 216.57 201.02 168.21 141.30 115.55
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 2,079.71 1,843.53 1,939.52 2,008.79 1,993.97 1,392.25
Operating Profit 279.16 224.57 261.59 252.09 274.39 616.14
Interest 14.55 14.76 16.10 16.47 8.29 5.83
Gross Profit 264.61 209.81 245.49 235.62 266.10 610.31
Depreciation 80.17 71.92 62.85 46.13 43.26 38.92
Profit Before Tax 184.44 137.89 182.64 189.49 222.84 571.39
Current Tax 40.55 24.74 37.01 46.26 57.01 145.55
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 6.17 12.15 10.21 3.25 0.17 -18.72
Reported Net Profit 137.72 101.00 135.42 139.98 165.66 444.56
Extraordinary Items -8.95 -0.13 0.07 -0.27 -11.05 -0.05
Adjusted Net Profit 146.67 101.13 135.35 140.25 176.71 444.61
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 1,401.82 1,324.30 1,218.23 1,101.75 971.31 550.23
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 29.35 23.48 29.35 23.50 35.22 23.48
P & L Balance carried down 1,510.19 1,401.82 1,324.30 1,218.23 1,101.75 971.31
Dividend 29.35 23.48 29.35 23.50 35.22 23.48
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 50.00 40.00 50.00 40.00 40.00 60.00
Dividend Per Share(Rs) 1.00 0.80 5.00 4.00 4.00 6.00
Earnings Per Share-Unit Curr 4.69 3.44 23.07 23.84 28.22 75.72
Earnings Per Share(Adj)-Unit Curr 4.69 3.44 4.61 4.77 5.64 15.14
Book Value 61.26 57.48 274.46 256.61 236.80 214.69
Book Value(Adj)-Unit Curr 61.26 57.48 54.89 51.32 47.36 42.94

Shareholding Pattern

  • Promoter Group

    62.28%

  • Public Share Holding

    37.72%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 176,815,175 60.24 176,815,175 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,984,825 2.04 5,984,825 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 182,800,000 62.28 182,800,000 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 14,300,533 4.87 14,300,533 73
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 56,049 0.02 5,049 6
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,215,579 0.41 1,215,579 4
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 15,572,161 5.31 15,521,161 83
2] Non Institution
Bodies Corporate 7,149,316 2.44 7,133,816 364
Clearing Members 243,623 0.08 243,623 31
Directors of their Relatives 0 0.00 0 0
Employees 54,056 0.02 54,056 124
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 4,169,725 1.42 4,169,725 1,880
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 3,867,058 1.32 3,867,058 2,051
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 14,916,873 5.08 14,916,873 45
Individuals holding nominal share capital up to Rs. 1 lakh 64,174,727 21.86 62,061,602 114,670
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 7,020 0.00 7,020 3
Others 34,800 0.01 34,800 2
Sub Total 95,155,349 32.42 93,026,724 119,223
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 293,527,510 100.00 291,347,885 119,311

Company Background

IOL Chemicals & Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • IOL Chemicals & Pharmaceuticals Ltd
  • BSE Code : 1973.0
  • ISIN : INE485C01029

  • Incorporation Year

    1986

  • Registered Office

    Trident Complex
    Raikot Road Barnala, Sangrur,
    Punjab-148101

  • Telephone

    91-01679-244701-07

  • FAX

    91-01679-244708

  • Chairman

    R M Malla

  • Managing Director

  • Company Secretary

    Abhay Raj Singh

  • Auditor

    Ashwani & Associates

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Alankit Assignments Ltd
    205/208,
    Anarkali Market,Jhandewalan Extn
    Mumbai - New Delhi - 110055

IOL Chemicals & Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
IOL Chemicals 197.45 2,340.34 2,319.06 34.46 10.60
Abbott India 25,910.10 7,217.19 6,929.05 34.10 43.78
Astrazeneca Phar 6,674.55 2,304.07 2,275.58 98.37 27.86
Glaxosmi. Pharma 2,800.45 3,932.76 3,790.20 44.74 58.17
Novartis India 2,080.85 393.10 354.33 52.55 15.94
Cipla 1,372.25 20,102.60 18,979.95 36.06 13.88
Bliss GVS Pharma 690.10 773.53 729.81 64.14 12.51
Amrutanjan Healt 490.20 520.13 502.55 26.26 24.16
Fermenta Biotec. 465.35 474.15 450.25 21.73 18.77
Guj. Themis Bio. 421.05 168.25 165.82 112.58 18.05
Ambalal Sarabhai 39.87 19.52 3.94 73.83 6.77